Table 3.
Population and Time Period of Interest | Number of Injuries, n (%) | Regression Analysis | ||
---|---|---|---|---|
Testosterone Use | Control | aORa (95% CI) | p - value | |
All Patients | 3,198 (0.76) | 2,081 (0.49) | 1.24 (1.15 - 1.33) | < 0.001 |
Male | 2,565 (0.74) | 1,630 (0.47) | 1.38 (1.29 - 1.49) | < 0.001 |
35 to 45 | 651 (0.81) | 441 (0.55) | 1.40 (1.21 - 1.61) | < 0.001 |
46 to 55 | 846 (0.82) | 567 (0.55) | 1.28 (1.13 - 1.46) | < 0.001 |
56 to 65 | 710 (0.76) | 435 (0.47) | 1.51 (1.31 - 1.74) | < 0.001 |
66 to 75 | 358 (0.53) | 187 (0.27) | 1.66 (1.35 - 2.03) | < 0.001 |
Female | 633 (0.81) | 451 (0.58) | 1.44 (1.27 - 1.64) | < 0.001 |
35 to 45 | 74 (0.73) | 58 (0.57) | 1.29 (0.89 - 1.87) | 0.175 |
46 to 55 | 241 (0.85) | 185 (0.65) | 1.33 (1.08 - 1.64) | 0.007 |
56 to 65 | 244 (0.87) | 167 (0.59) | 1.54 (1.25 - 1.90) | < 0.001 |
66 to 75 | 74 (0.66) | 41 (0.36) | 1.82 (1.21 - 2.75) | 0.004 |
Bold indicated statistical significance (p < 0.05)
aOR Adjusted odds ratio, CI Confidence interval
aadjusted used multivariable logistic regression to additionally control for hypogonadism, chronic kidney disease, osteoporosis, overweight/obesity (body mass index > 25), class III obesity (body mass index > 40), alcohol use, osteoarthritis, lung disease, congestive heart failure, and dementia